Heart failure & cardiomyopathiesCohort study
Cancer and heart failure: prevalence, incidence, and prognosis in Scotland
- Population-based cohort study
- health records
- regional (Scotland)
Authors' conclusion
Patients with HFexp have a slightly higher risk of cancer overall, but this may vary according to cancer type. Patients with both cancer and HFexp have a poor prognosis with a similar proportion of deaths attributed to cancer and cardiovascular disease.
Study context
- Population
- People aged >50 years in a Scottish region30,312 (9.6%) HFexp
- Participants
- 317,178 people
- Exposure
- HFexp vs no HFexp; cancer vs no cancer
- Outcome
- Incident cancer, mortality and cause of death
Main finding
Annual mortality
Incidence rate ratio
1.10
P < 0.001
By group
Neither cancer nor HFexp
<3%
Cancer, no HFexp
6.3%
Women · Men 9.0% · Main cause of death cancer
HFexp, no cancer
6.6% to 18.4%
Cancer and HFexp
14.5% to 28.4%
As reported in the abstract
Observational data: associations, not effects.
Further findings
Place of death
- Few patients died at home
- ∼20%
Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.
Original publication
Summarised from the published abstract; every number is checked against it